BeiGene
BGNE
#919
Rank
NZ$34.68 B
Marketcap
$317.04
Share price
0.49%
Change (1 day)
33.34%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Sustainability Reports

Thumbnail BeiGene
 Sustainability Report 2023

Sustainability Report 2023

Language: English

View Sustainability Report
Thumbnail BeiGene
 Sustainability Report 2020

Sustainability Report 2020

Language: English

View Sustainability Report